Adalimumab-Induced Epstein-Barr Virus-Related Lymphoproliferative Disorder on FDG PET/CT

被引：0
|
作者：
Ward, John [1 ]
Noy, Ariela [2 ]
Ulaner, Gary [3 ]
Riedl, Christopher [3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Southampton, Hants, England
[2] Mem Sloan Kettering Canc Ctr, Dept Med Oncol, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Nucl Med, 1275 York Ave, New York, NY 10065 USA
来源：
CLINICAL NUCLEAR MEDICINE | 2018年 / 43卷 / 05期
关键词：
F-18-FDG PET; CT; adalimumab; Epstein Barr virus-related lymphoproliferative disorder;
D O I：
10.1097/RLU.0000000000002054
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Adalimumab is a fully human chimeric tumor necrosis factor inhibitor used to treat immune-mediated disorders such as psoriatic arthritis. We present a 51-year-old woman with psoriatic arthritis on methotrexate and infliximab for 12 years. Adalimumab replaced infliximab because of worsening symptoms. Following 3 doses administered 1 week apart, rapidly enlarging cervical lymph nodes developed. Biopsy revealed Epstein-Barr virus-related polymorphic lymphoproliferative disorder. F-18-FDG PET/CT demonstrated widespread hypermetabolic lymphadenopathy; follow-up at 5 weeks off adalimumab revealed almost complete resolution of this adenopathy. This is most consistent with Epstein-Barr virus-related lymphoproliferative disorder secondary to tumor necrosis factor inhibition.
引用
收藏
页码：344 / 345
页数：2
相关论文
共 50 条
  • [31] Chorioretinal post-transplant lymphoproliferative disorder induced by the Epstein-Barr virus
    Demols, PF
    Cochaux, PM
    Velu, T
    Caspers-Velu, L
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (01) : 93 - 95
  • [32] IS WARTHINS TUMOR AN EPSTEIN-BARR VIRUS-RELATED DISEASE
    GALLO, O
    INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (05) : 756 - 757
  • [33] Adoptive immunotherapy for Epstein-Barr virus-related lymphoma
    Smith, CA
    Ng, CYC
    Loftin, SK
    Li, CF
    Heslop, HE
    Brenner, MK
    Rooney, CM
    LEUKEMIA & LYMPHOMA, 1996, 23 (3-4) : 213 - 220
  • [34] Epstein-Barr virus-related dacryocystitis: a case report
    Sternberg, J.
    Lambiel, S.
    Van, H. Cao
    Massa, H.
    Landis, B. N.
    JOURNAL OF MEDICAL CASE REPORTS, 2022, 16 (01)
  • [35] EPSTEIN-BARR VIRUS-RELATED ANTIBODY PATTERN IN UVEITIS
    SUNAKAWA, M
    OKINAMI, S
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 1985, 29 (04) : 423 - 428
  • [36] Laboratory assays for Epstein-Barr virus-related disease
    Gulley, Margaret L.
    Tang, Weihua
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (04): : 279 - 292
  • [37] Molecular diagnosis of Epstein-Barr virus-related diseases
    Gulley, ML
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2001, 3 (01): : 1 - 10
  • [38] Macrophage involvement in Epstein-Barr virus-related tumors
    Shimakage, Misuzu
    Sakamoto, Haruhiko
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2010, 1 (02) : 285 - 291
  • [39] EPSTEIN-BARR VIRUS-RELATED LOCALIZED HEPATIC LYMPHOPROLIFERATIVE DISORDERS AFTER LIVER-TRANSPLANTATION
    RAYMOND, E
    TRICOTTET, V
    SAMUEL, D
    REYNES, M
    BISMUTH, H
    MISSET, JL
    CANCER, 1995, 76 (08) : 1344 - 1351
  • [40] Epstein-barr virus associated lymphoproliferative disorder of the anal margin
    Homsi, Toufik
    Balaton, Andre
    Du Puy Montbrun, Thierry
    Lazure, Thierry
    Mansouri, Douha
    De Pinieux, Isabelle
    Molina, Thierry
    Raphael, Martine
    Molinie, Vincent
    MODERN PATHOLOGY, 2006, 19 : 128 - 128
12345